 |
|
Update on FDA Regulation of In Vitro Diagnostic Devices
Steven Gutman, MD, MBA;
Kimber Richter, MD;
Susan Alpert, PhD, MD
JAMA. 1998;280:190-192.
|
|
| Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings. |
|
|
|
THE FOOD AND Drug Administration's (FDA's) authority for regulation of laboratory tests (in vitro diagnostic devices or IVDs) was established as a result of passage of the Medical Device Amendments of 1976.1 Under this law, all medical devices (including IVDs) are subject to a variety of controls, including the requirement for manufacturers to register with the FDA and list their products, to comply with Current Good Manufacturing Practice, and to report serious device failures. This law provided the agency, for the first time in the late 1970s, with an inventory of tests already in the marketplace, tools to require that manufacturing practices be sound, and a system to ensure that serious problems are identified and remedied. In addition, the law put into place requirements for premarket review of medical devices entering the market for the first time.
As a . . . [Full Text of this Article]
From the Office of Device Evaluation, Center for Devices and Radiological Health, Food and Drug Administration, Rockville, Md.
 CiteULike  Connotea  Del.icio.us  Digg  Reddit  Technorati  Twitter
What's this?
RELATED ARTICLE
Are Current Regulations for Approval of In Vitro Diagnostic Devices Adequate?
Dorothy Levine, Richard Grossberg, Richard Tilton, Peter Banks, and Alvin Rosenfeld
JAMA. 1998;280(2):187-189.
EXTRACT
| FULL TEXT
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
A Perspective on Challenges and Issues in Biomarker Development and Drug and Biomarker Codevelopment
Taube et al.
JNCI J Natl Cancer Inst 2009;101:1453-1463.
ABSTRACT
| FULL TEXT
|
